Soft tissue sarcomas: Introduction to the Virchows Archiv review issue

Virchows Archiv

Volumn 456, Issue 2, 2010, Pages 107-109

  Guillou, Louis ^a   Hogendoorn, Pancras C W ^b   Bosman, Fred T ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RNA BINDING PROTEIN EWS;

CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIAGNOSTIC VALUE; EDITORIAL; EWING SARCOMA; GENE EXPRESSION PROFILING; GENOME ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LIPOSARCOMA; PATHOLOGIST; PATHOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION; TUMOR GROWTH; GENETICS; KARYOTYPING; SARCOMA; WORLD HEALTH ORGANIZATION;

GENE EXPRESSION PROFILING; HUMANS; KARYOTYPING; SARCOMA; WORLD HEALTH ORGANIZATION;

EID: 77950352242     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0875-y     Document Type: Editorial

References (28)

1. Hogendoorn PCW, Collin F, Daugaard S et al (2004) Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment. Eur J Cancer 40:1644-1654
2. Fletcher CDM, Unni KK, Mertens F (2002) WHO classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon
3. Fletcher CDM (1992) Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16:213-228
4. Fletcher CDM (1994) Haemangiopericytoma-a dying breed? Reappraisal of an 'entity' and its variants: a hypothesis. Curr Diagn Pathol 1:19-23
5. Bovee JVMG, Hogendoorn PCW (2010) Molecular pathology of sarcomas: concepts and clinical implications. Virchows Arch. doi:10.1007/s00428-009-0828-5
6. Mertens F, Panagopoulos I, Mandahl N (2010) Genomic characteristics of soft tissue sarcomas. Virchows Arch. doi:10.1007/ s00428-009-0736-738
7. Beck AH, West RB, Van De Rijn M (2010) Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers. Virchows Arch. doi:10.1007/s00428-009-0774-2
8. Mohseny AB, Szuhai K, Romeo S et al (2009) Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol 219:294-305
9. Cironi L, Provero P, Riggi N et al (2009) Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1. PLoS ONE 4:e7904
10. Riggi N, Cironi L, Provero P et al (2005) Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65:11459-11468 (Pubitemid 41821703)
11. Riggi N, Cironi L, Suva ML et al (2007) Sarcomas: Genetics, signalling, and cellular origins. Part 1: the fellowship of TET. J Pathol 213:4-20 (Pubitemid 47354561)
12. Riggi N, Cironi L, Provero P et al (2006) Expression of the FUSCHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res 66:7016-7023 (Pubitemid 44197677)
13. Riggi N, Suva ML, Suva D et al (2008) EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res 68:2176-2185 (Pubitemid 351521790)
14. Suva ML, Cironi L, Riggi N et al (2007) Sarcomas: Genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations. J Pathol 213:117-130 (Pubitemid 47612234)
15. Suva ML, Riggi N, Stehle JC et al (2009) Identification of cancer stem cells in Ewing's sarcoma. Cancer Res 69:1776-1781
16. Ladanyi M (1995) The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 4:162-173
17. Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations in c-kit in human gastrointestinal stromal tumors. Science 279:577-580 (Pubitemid 28067289)
18. Dei Tos AP (2001) Lipomatous tumours. Curr Diagn Pathol 7:8-16
19. Romeo S, Dei Tos AP (2010) Soft tissue tumors associated with EWSR1 translocation. Virchows Arch. doi:10.1007/s00428-009- 0854-863
20. Fisher C (2010) Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch. doi:10.1007/s00428-009- 0776-780
21. Coindre JM, Pedeutour F, Aurias A (2010) Well-differentiated and dedifferentiated liposarcomas. Virchows Arch. doi:10.1007/ s00428-009-0815-x
22. Guillou L, Aurias A (2010) Soft tissue sarcomas with complex genomic profiles. Virchows Arch. doi:10.1007/s00428-009- 0853-854
23. Willems SM, Schrage YM, Baelde JJ et al (2008) Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition. Histopathology 52:465-474
24. Willems SM, Mohseny AB, Balog C et al (2009) Cellular/ intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. J Cell Mol Med 7:1301
25. Graadt Van Roggen JF, Hogendoorn PCW, Fletcher CDM (1999) Myxoid tumours of soft tissue. Histopathology 35:291-312
26. Willems SM, Wiweger M, Frans Graadt Van Roggen J et al. (2010) Running GAGs: myxoid matrix revisited. What's in it for the pathologist? Virchows Arch. doi:10.1007/s00428-009- 0822-y
27. Liegl-Atzwanger B, Fletcher JA, Fletcher CMD (2010) Gastrointestinal stromal tumors. Virchows Arch. doi:10.1007/ s00428-010-0891-y
28. Verweij J, Van Oosterom A, Blay JY et al (2003) Imatinib mesylate (STI-571 Glivec(R), Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. Eur J Cancer 39:2006-2011